Cervical cancer kills 3,700 American women a year ["Cervical Cancer Vaccine
Gets Injected With a Social Issue; Some Fear a Shot for Teens Could Encourage
Sex," news story, Oct. 31].
My aunt Lucy Callaway died a horrible death from cervical cancer. My wife
escaped death only through major surgery.
The concerns about vaccination voiced by the Christian Medical and Dental
Associations and the Family Research Council reveal a "better dead than red"
mentality by which these organizations place their "values" above the lives
of millions of women.
For years, chemotherapy has been used as treatment for mesothelioma to shrink
tumors. More recently, doctors have used surgery in combination with chemotherapy
with more success.
In addition, newer chemotherapy drugs in combination with surgery has increased
survival rates of mesothelioma patients.
Radiation has been used to control cancer symptoms such as pain, but it is
not a primary treatment for mesothelioma. It is also used in combination
with other treatments for mesothelioma and may possibly assist in killing
cancer cells after surgery to prevent further growth of cancer cells in the
chest area.
Much more research is required to improve treatment options through clinical
trials. Clinical trials are used to evaluate new cancer treatments and their
effectiveness. They are an important aspect of improving treatments and the
ultimate prognosis of cancer patients.
Mesothelioma patients who participate in clinical trials are able to receive
new treatments before they are available to other patients.
Clinical trials have three phases. Phase I trails are the first studies of
a new treatment. The goals are to determine the correct dosage and the side
effects. Phase I trials are only offered to patients who haven't responded
to other approved treatments.
Phase II trials are further studies of treatments proven to be effective
from phase I trials. They are a continuation of determining treatment safety
and effectiveness on a particular type of cancer.
Phase III trials are used to compare a new treatment method with a currently
used treatment program. Doctors can thus determine if the new treatment is
more or less effective than the already approved treatment.
A patient must be willing to partcipate and provide written consent prior
to starting a clinical trial. The use of clinical trials is very important
in improving the treatments used in the fight against mesothelioma.
Over the past few years treatments have improved for treating mesothelioma,
but further clinical trials are needed to continue mesothelioma treatment
methods.
DISCLAIMER
- Please note that all articles on this web site does not constitute
professional advice. All articles are intended to provide a general view
of many topical subjects from a variety of sources. We are not responsible
for the content or any sponsored links that you may choose to visit from
this web site. We suggest you to consult a solicitor and your doctor for
advice relevant to you own situation before making any important decisions.
The author is not an expert in any given field. By printing, downloading,
or using you agree to our full terms. Below is a summary of some of the terms.
If you do not agree to the full terms, do not use the information. We are
only publishers of this material, not authors. Information may have errors
or be outdated. Some information is from historical sources or represents
opinions of the author. It is for research purposes only. The information
is "AS IS", "WITH ALL FAULTS". User assumes all risk of use, damage, or injury.
You agree that we have no liability for any damages. We are not liable for
any consequential, incidental, indirect, or special damages. You indemnify
us for claims caused by you.